NCT06326814 A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults Status COMPLETED Phase PHASE1
NCT06325488 Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease Status RECRUITING Phase N/A
NCT06293053 A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis Status RECRUITING Phase PHASE3
NCT06290141 A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Status RECRUITING Phase PHASE3
NCT06290128 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06280391 A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE2
NCT06258577 Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency Status NOT_YET_RECRUITING Phase N/A
NCT06258057 Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06241118 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor Status RECRUITING Phase PHASE3
NCT06224348 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids Status COMPLETED Phase PHASE3
NCT06216158 Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06208306 A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06203912 Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT06193304 A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth Status COMPLETED Phase PHASE1
NCT06192576 A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD) Status RECRUITING Phase N/A
NCT06192563 A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment Status RECRUITING Phase N/A
NCT06191315 Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) Status ENROLLING_BY_INVITATION Phase PHASE3